Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    ISSN: 1432-1238
    Keywords: Sedation ; Propofol ; Midazolam ; Intensive care unit ; Surgical ; Mental disorders ; Sleep disorders ; Hospital Anxiety and Depression Scale
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Objective To assess and compare the impact of overnight sedation with midazolam or propofol on anxiety and depression levels, as well as sleep quality, in non-intubated patients in intensive care. Design Open, comparative, prospective, randomised study. Setting Surgical intensive care unit (ICU) in a university hospital. Patients 40 conscious patients expected to stay in the ICU for at least 5 days who were admitted following trauma or elective orthopaedic, thopaedic, thoracic or abdominal surgery. Measurements and results Evaluation of a self-assessment scale (Hospital Anxiety and Depression Scale, HAD) on the day following the 1st, 3rd and 5th night of sedation with either midazolam or propofol. Heart rate, pulse oximetry and blood gases were monitored. Eight patients were excluded from the analysis. The level of anxiety was severe (HAD〉10) in 31% of the patients receiving midazolam and in 26% (p=0.1) receiving propofol after the first night of sedation, with no significant improvement over the next few days. The levels of depression remained high (〉10) in 54% of patients receiving midazolam, and in 16% of the patients receiving propofol (p=0.15). Sleep quality tended to improve during the study in the two groups. Conclusions These data show that half of the patients in the ICU experienced high levels of anxiety and depression during the first 5 postoperative or post-trauma days in the ICU. The beneficial effects of sedation on sleep quality were comparable for midazolam and propofol, regardless of a lack of improvement in anxiety and depression. However, an improved quality of sleep could help to re-establish a physiological night and day rhythm.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1432-1238
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Objective: To assess and compare the impact of overnight sedation with midazolam or propofol on anxiety and depression levels, as well as sleep quality, in non-intubated patients in intensive care. Design: Open, comparative, prospective, randomised study. Setting: Surgical intensive care unit (ICU) in a university hospital. Patients: 40 conscious patients expected to stay in the ICU for at least 5 days who were admitted following trauma or elective orthopaedic, thoracic or abdominal surgery. Measurements and results: Evaluation of a self-assessment scale (Hospital Anxiety and Depression Scale, HAD) on the day following the 1st, 3rd and 5th night of sedation with either midazolam or propofol. Heart rate, pulse oximetry and blood gases were monitored. Eight patients were excluded from the analysis. The level of anxiety was severe (HAD 〉10) in 31% of the patients receiving midazolam and in 26% (p=0.1) receiving propofol after the first night of sedation, with no significant improvement over the next few days. The levels of depression remained high (〉10) in 54% of patients receiving midazolam, and in 16% of the patients receiving propofol (p=0.15). Sleep quality tended to improve during the study in the two groups. Conclusions: These data show that half of the patients in the ICU experienced high levels of anxiety and depression during the first 5 postoperative or post-trauma days in the ICU. The beneficial effects of sedation on sleep quality were comparable for midazolam and propofol, regardless of a lack of improvement in anxiety and depression. However, an improved quality of sleep could help to re-establish a physiological night and day rhythm. Key words Sedation · Propofol · Midazolam · Intensive care unit · Surgical · Mental disorders · Sleep disorders · Hospital Anxiety and Depression Scale
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    ISSN: 1432-2072
    Keywords: Moclobemide ; MAOI ; RIMA ; Fluvoxamine ; 5-HT reuptake inhibitor ; Depression
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract The efficacy and tolerability of moclobemide and fluvoxamine, two new types of antidepressant agents, were compared in a multicentre, double-blind prospective study of patients with a diagnosis of major depressive episode (DSM III). Patients were randomized to receive either moclobemide (150 mg) or fluvoxamine (50 mg) twice daily for 7 days, immediately following a washout period of at least 1 week. Dosages were increased where necessary on day 8, to a maximum of moclobemide 450 mg or fluvoxamine 200 mg and in most cases were maintained at these levels for the remainder of the study period (4–6 weeks). Both treatment groups showed a marked antidepressant effect. While both treatments were well tolerated, moclobemide showed a more favourable side-effect profile than fluvoxamine. Of the 126 patients eligible for evaluation, 34 withdrew from therapy, 22% in the moclobemide group and 30% in the fluvoxamine group. Adverse events were reported in 41.8% of patients treated with moclobemide compared to 60.3% of patients in the fluvoxamine group. Reports of dry mouth and other anticholinergic effects were more frequent among those treated with fluvoxamine. A greater number of gastrointestinal complaints, especially nausea, also occurred in the fluvoxamine-treated patients.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    ISSN: 1432-2072
    Keywords: Depression ; Onset of action ; Moclobemide ; Widlöcher retardation scale ; HAMD ; MADRS
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract The aim of this paper is to focus on methodological problems related to clinical studies on the onset of action of antidepressants, especially moclobemide. The methodological discussion proposed focuses on: -global efficacy as a function of time; -proposals for a specific approach to the study of the onset of action; -quality of the response and onset of action; -the dimensional level and the onset of action.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...